BNP Paribas Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.2K Buy
1,026
+437
+74% +$8.34K ﹤0.01% 2046
2025
Q4
$14K Buy
+589
New +$15.2K ﹤0.01% 2057
2025
Q3
Sell
-424
Closed -$7K 2061
2025
Q2
$7K Buy
+424
New +$7.47K ﹤0.01% 1903
2016
Q1
Sell
-340,617
Closed -$2.43M 1085
2015
Q4
$2.43M Sell
340,617
-7,096
-2% -$57.5K 0.02% 622
2015
Q3
$2.7M Sell
347,713
-77,840
-18% -$641K 0.02% 606
2015
Q2
$4.11M Sell
425,553
-53,454
-11% -$496K 0.03% 550
2015
Q1
$3.56M Buy
+479,007
New +$3.5M 0.03% 573

Other funds holding STAA

BNP Paribas Asset Management's STAA Position: Q1 2026 in Review

BNP Paribas Asset Management increased its STAAR Surgical (STAA) stake by 74% in Q1 2026, buying an estimated $8.34K and bringing the position to 1,026 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2046.

BNP Paribas Asset Management first reported a position in STAA in Q1 2015 and has held it in 7 quarters since. The position peaked at $4.11M in Q2 2015. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • BNP Paribas Asset Management held 1,026 shares of STAAR Surgical worth $19.2K as of Q1 2026.
  • BNP Paribas Asset Management bought 437 STAAR Surgical shares in Q1 2026, an estimated $8.34K.
  • STAAR Surgical made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2046 holding.
  • BNP Paribas Asset Management first reported a position in STAAR Surgical in Q1 2015 and has held it in 7 quarters since.
  • BNP Paribas Asset Management's STAAR Surgical position peaked at $4.11M in Q2 2015.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.